A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

Black gay men face major PrEP access gaps due to cost, stigma, mistrust, and provider silence—despite high HIV impact; ...

Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer ...

PrEP is one of the most powerful tools in HIV prevention. Yet for many Black LGBTQ+ people, getting access to the medication is far harder than it should be.

Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis, or ...

The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that causes AIDS. The injectable drug lenacapavir was approved in June and is ...

The tool can be used to find providers that offer HIV testing and medications that prevent the virus, which causes AIDS.

Yeztugo (lenacapavir) is more than 99.9 percent effective at protecting at-risk people from HIV — but for many, accessing the drug may be a challenge. Yeztugo (lenacapavir) is the first and only ...

A couple of years ago, Matthew Hurley got the kind of text people fear. It said: "When was the last time you were STD tested?" Someone Hurley had recently had unprotected sex with had just tested ...

Medications have kept Tori Samuel’s HIV at bay for decades. The part-time worker from Ocala, Florida, has thrived, marrying ...

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and ...